Göksel Güz

Dr. Göksel Güz


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Medicine
Verified
Journal Article
Open access
GGGöksel Güz
Göksel Güz
SDSerdar Demirgan
Serdar Demirgan
Severe acute respiratory syndrome coronavirus-2 is a highly infectious pathogenic coronavirus, which has appeared toward the end of 2019. The virus seen all over the world caused a pandemic of an acute respiratory disease named coronavirus disease 2019 (Covid-19). It has been shown that the virus that uses angiotensin-converting enzyme 2 receptors is causing endothelial dysfunction resulting in vascular inflammation and coagulopathy. It is possible to assess endothelial dysfunction by the flow-mediated dilatation (FMD) technique. Our study aimed to demonstrate the effect of endothelial dysfunction assessed using the FMD on prognosis and mortality in the patients hospitalized with the diagnosis of Covid-19. In this prospective observational study, endothelial functions of 94 patients hospitalized due to the Covid-19 in the ward or intensive care unit (ICU) were evaluated by FMD. The relationship among endothelial dysfunction and prognosis of disease, biochemical parameters, lung involvement, and mortality was investigated. We found that the FMD% values of the Covid-19 ICU patients compared to those followed up in the ward (2.66 ± 0.62 vs. 5.23 ± 1.46/P < .001) and those who died due to Covid-19 compared to those who were discharged alive (2.57 ± 0.22 vs. 4.66 ± 1.7/P < .001) were significantly lower. There were moderate negative correlation between FMD% and peak values of D-dimer (r = −0.52, P < .001), troponin (r = −0.45, P < .001), ferritin (r = −0.47, P < .001), lactate dehydrogenase (r = −0.49, P < .001), and white blood cells count (r = −0.23, P = .024). Lower FMD% was associated with higher lung parenchymal involvement (P < .001). The optimum cutoff point of FMD in predicting mortality was found to be 3.135% (sensitivity: 1, selectivity: 0.70). According to our results, lower FMD% was associated with higher lung parenchyma involvement, ICU admission, and mortality rate in Covid-19 patients. The best cutoff point for predicting mortality of FMD was 3.135%. Nevertheless, largescale, multicenter studies are needed to evaluate lower FMD values as a risk factor for mortality in Covid-19.

5 April 2023 in Kocatepe Tıp Dergisi
Verified
Journal Article
Open access
PDF file
GGGöksel Güz
Göksel Güz
AMAÇ: Çalışmamızın amacı hastanemiz yoğun bakım ünitesinde, solunum yetersizliği nedeniyle yatan SARS-COV2 hastalarının elektrokardiyografisinin (EKG) fragmente QRS (f-QRS) varlığı açısından incelenmesi, f-QRS varlığının mortalite, yoğun bakım yatış süresi ve diğer prognostik biyokimyasal tetkikler ile ilişkisini incelemektir. GEREÇ VE YÖNTEM: Hastanemiz yoğun bakım ünitesinde Haziran 2020 - Ocak 2021 tarihleri arasında yatan 122 ardışık SARS-COV2 hastası çalışmaya dahil edildi. Hastaların EKG’si f-QRS varlığı açısından değerlendirildi. F-QRS varlığına göre hastalar iki gruba ayrıldı. F-QRS varlığı iki deneyimli kardiyolog tarafından teyit edildi. Hastaların biyokimyasal değerlerinden D-dimer, ferritin, CRP, hemogram, troponin değerleri, yoğun bakım yatış süresi, mortalite oranları bu iki grup arasında karşılaştırıldı. BULGULAR: Yoğun bakım hastalarının %22’sinde f-QRS saptandı. F-QRS grubundaki hastaların CRP, d-Dimer, Troponin değerleri, f-QRS görülmeyen covid grubuna göre anlamlı yüksek idi. F-QRS grubunda mortalite % 38 iken, diğer grupta mortalite % 22 idi (p<0.001). SARS-COV2 hastalarında f-QRS görülme oranı yüksektir. SONUÇ: SARS-COV2 hastalarında EKG’de f-QRS varlığı kardiyovasküler olayları ve mortaliteyi öngörebilir

27 January 2023
Verified
Book
Open access
PDF file
BCBüşra Ceylan
Büşra Ceylan
MSMehmet Saygı
Mehmet Saygı
NKNagehan Kucukler
Nagehan Kucukler
GGGöksel Güz
Göksel Güz
ADAykut Demirkıran
Aykut Demirkıran
UIUfuk İyIgün
Ufuk İyIgün
Daha Önce Major Gastrointestinal Kanaması Olan ve İskemik Risk Skoru Yüksek Atrial Fibrilasyon Hastasına Yaklaşım Büşra CEYLAN Akut Koroner Sendrom Geçiren ve Af Nedeniyle Yoak Kullanan Hastada Antikoagülan/Antiplatelet Yönetimi Mehmet SAYGI Paroksismal Atriyal Fibrilasyonu Olan Hastada Ritm Kontrolü Nagehan KÜÇÜKLER Atrioventriküler Tam Blok Hastasında Tedavi Yaklaşımı Göksel GÜZ Vasovagal Senkobu Olan Hastada Tedavi Yaklaşımı Aykut DEMİRKIRAN Sekonder Mitral Yetersizliğinde Tanı ve Tedavi Seçenekleri Cansu EBREN İleri Aort Darlığında Traskateter Aortik Valve Replasmanı (Tavı) Tedavisi Mehmet ALTUNOVA Sol Taraf Kalp Hastalığına Eşlik Eden Triküspid Yetersizliğinin Tedavisi Çiğdem KOCA Diyabetes Mellitus Hastalarında Kardiyovasküler Risk Tahmini ve Risk Faktörlerinin Uygun Tedavisi Aykut BULUT Kronik Böbrek Hastalarında Kardiyovasküler Risk Yönetimi Hatice DUMAN Kanser Hastalarında Kardiyotoksisiteden Korunma ve Kardiyovasküler Risk İmran CEREN Atrial Septal Defekt Ömer DOĞAN Opere Fallot Tetralojisi Hastalarının Takibi ve Takip Sürecinde Sık Karşılaşılan Sorunların Tedavisi Nazlı TURAN ŞERİFLER Aort Koarktasyonu Tanısı ve Tedavisi Gökhan AYDIN Koroner Arter Anomalisi Olan Hastalarda Tanı ve Uygun Tedavi Seçenekleri Sayın ÇAĞLAR Spor Müsabakalarına Katılacak Sporcularda Kardiyolojik Değerlendirme Deniz AYTEKİN Düşük Ejeksiyon Fraksiyonlu Kalp Yetersizliği Hastalarının Yapabileceği Sporlar İskender KADİFE Antiplatelet ve Antiagregan Kullanımı İle İlgili Öneriler Rauf AVCI Tam Revaskülarizasyon ve Aşamalı Revaskülarizasyon Önerileri Süleyman KALAYCI Diyabetik Nstemı Hastalarına Yaklaşım Gülçin Halise GÖRGÜLÜ Akut Kalp Yetersizliği Hastasına Yaklaşım Gülbin SEYMAN ÇETİNKAYA İleri Evre Kalp Yetersizliği Hastalarında Medikal Tedavi Dışı Tedavi Yöntemleri Samet YILMAZ Korunmuş EF’li Kalp Yetersizliği Olgusu Özlem KARACA Kardiyorenal Sendrom Tanı ve Tedavisi Ufuk İYİGÜN

Verified
Journal Article
Open access
PDF file
GGGöksel Güz
Göksel Güz
RKrasim onur Karaoglu
rasim onur Karaoglu
SSSEZEN KUMAŞ SOLAK
SEZEN KUMAŞ SOLAK
SDSerdar Demirgan
Serdar Demirgan
Objective: Restless leg syndrome (RLS) has been associated with an increased risk of vascular disorders, which suggests that endothelial dysfunction plays an important role in the pathogenesis of RLS. In this study, we aimed to evaluate coronary endothelial dysfunction in RLS patients using coronary flow velocity reserve (CFVR) and compared it with healthy controls. Methodology: In this study, the participants were divided into two groups as group RLS (n = 42) and group HC (n = 41). The primary outcome was the CFVR compared between groups. The number of participants with a CFVR value below 2.0 was also evaluated. In addition, a correlation between the international restless legs scale (IRLS) and CFVR, white-blood-cell-count (WBC), and C-reactive protein (CRP) was analyzed. Secondary outcomes were the WBC, hemoglobin, CRP, blood glucose, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and creatinine compared between the two groups. Results: In the group RLS, CFVR was measured lower than healthy controls (p < 0.001). When the groups were compared in terms of the number of participants with a CFVR less than 2.0, the difference between the groups was significant (p < 0.001, 0/41 in group HC and 14/42 in group RLS). Patients with RLS had higher WBC and CRP values. There was a negative correlation between CFVR and IRLS (p < 0.001). The relationship between WBC, CRP, and IRLS was not statistically significant (p = 0.691). Conclusions: In this exploratory study, RLS patients had lower CFVR compared with healthy controls and a negative correlation was observed between RLS severity and CFVR. These findings warrant confirmation in larger, prospectively designed studies with multivariable adjustment. Therefore, we think that it may be beneficial to follow-up patients with RLS in terms of coronary heart disease. Clinical trial number: not applicable.